The first vaccinations against COVID-19 continue in Extremadura among the inmates of the Rosalba de MÃ rida residence, on the first day of vaccination against Covid-19 in Spain, in MÃ rida, in Extremadura (Spain), on 27 December 2020. The first doses of the vaccine developed by Pfizer and BioNtech laboratories arrived in Spain yesterday, December 26, at a Pfizer warehouse in Guadalajara by land from Puurs (Belgium). Starting Monday, weekly deliveries will be made to the autonomous communities with an average of 350,000 doses prioritized for four population groups: residents and health and social-health personnel in homes for the elderly and disabled; front-line health personnel; other health and social-health personnel and large non-institu
Choose your license
Rights Managed:
One-time editorial use in an online article, social media channels, internal presentation, website, newsletter, or blog.
One-time editorial use in a book, newspaper or magazine (excluding cover page), external presentation. Limited to 5,000 circulation. This includes the rights available in the Standard license.
Media Info
Credit: Lagencia
Media ID:
Recording Date: Dec 27, 2020
Media Size: 9,449×6,299 Pixels
The first vaccinations against COVID-19 continue in Extremadura among the inmates of the Rosalba de MÃ rida residence, on the first day of vaccination against Covid-19 in Spain, in MÃ rida, in Extremadura (Spain), on 27 December 2020. The first doses of the vaccine developed by Pfizer and BioNtech laboratories arrived in Spain yesterday, December 26, at a Pfizer warehouse in Guadalajara by land from Puurs (Belgium). Starting Monday, weekly deliveries will be made to the autonomous communities with an average of 350,000 doses prioritized for four population groups: residents and health and social-health personnel in homes for the elderly and disabled; front-line health personnel; other health and social-health personnel and large non-institu
Release Info: Do I need a release?
Captions may have been translated or enriched by an AI system.
For more information about AI-assisted captions, see AI-assisted captions.
Need a custom license?
If your intended use isn't covered by the available options (such as non-editorial purposes or specific distribution needs), contact us. Our team will be happy to provide a tailored offer based on your requirements.
